TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Novartis Norge AS
Closing information (x1000 EUR)
Closing information | 2019/12 | 2018/12 | 2017/12 |
Turnover | 140,177 | 127,223 | 123,958 |
Financial expenses | 230 | 130 | 163 |
Earnings before taxes | 5,225 | 3,786 | 3,868 |
Total assets | 49,068 | 39,709 | 43,392 |
Current assets | 48,761 | 39,315 | 42,970 |
Current liabilities | 29,484 | 24,386 | 30,677 |
Equity capital | 14,478 | 10,310 | 7,605 |
- share capital | 152 | 150 | 152 |
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Solvency | 29.5% | 26.0% | 17.5% |
Turnover per employee | |||
Profit as a percentage of turnover | 3.7% | 3.0% | 3.1% |
Return on assets (ROA) | 11.1% | 9.9% | 9.3% |
Current ratio | 165.4% | 161.2% | 140.1% |
Return on equity (ROE) | 36.1% | 36.7% | 50.9% |
Change turnover | 10,798 | 5,607 | -29,694 |
Change turnover % | 8% | 5% | -19% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.